Muscle Ossification: An Unusual Bone Development

what is ossification of muscle

Ossification of muscle, or myositis ossificans, is a condition where bone tissue forms in soft tissues or muscles. It is a type of heterotopic ossification (HO), which is when bone develops in soft tissues. Myositis ossificans is the most common form of heterotopic ossification, usually occurring in large muscles such as the arms or legs. It is caused by trauma or injury, and is most common in young, active people and athletes. The condition can be divided into three stages: early, intermediate, and mature. In the early phase, there is an inflammatory response and bone formation. This is followed by an intermediate phase of bone formation where calcification starts to occur and is visible on X-rays. During the maturation phase, mature bone forms and consolidates, and bone regression occurs. Treatment for myositis ossificans is typically non-surgical, focusing on immobilization, ice therapy, compression, and elevation of the affected limb.

Characteristics Values
Definition Heterotopic ossification (HO) is when bone tissue develops in soft tissues.
Common Causes Injury, major surgery, or trauma
Other Causes Spinal cord injury, head trauma, total hip replacement, amputation, bone fracture, traumatic brain injury (TBI), rare genetic diseases
Symptoms Painful, tender, enlarging mass or lump under the skin, reduced range of motion if near a joint
Most Common Sites Thigh, arm, intercostal spaces, erector spinae, pectoralis muscles, glutei, chest
Diagnosis X-ray, ultrasound, biopsy, CT scan
Treatment Nonsurgical methods, bed rest, ice therapy, compression, elevation, crutches, range of motion exercises
Prevention Reducing risk of injury, proper conditioning, stretching, adequate rest
Forms Myositis ossificans (most common), fibrodysplasia ossificans progressiva (FOP), progressive osseous heteroplasia (POH), myositis ossificans circumscripta, myositis ossificans progressiva

cyvigor

Myositis ossificans: nonhereditary and hereditary types

Myositis ossificans is a condition characterised by abnormal heterotopic ossification formation, typically involving muscles, tendons, ligaments, fascia, and aponeurosis. It is the most common form of heterotopic ossification, which is when bone tissue develops in soft tissues or muscles. Myositis ossificans can be categorised into nonhereditary and hereditary types.

Nonhereditary Myositis Ossificans

Nonhereditary myositis ossificans is the most common type of myositis ossificans. It is usually referred to simply as "myositis ossificans". Calcifications occur at the site of injured muscle, most commonly in the arms or in the quadriceps of the thighs. The term myositis ossificans traumatica is sometimes used when the condition is due to trauma. Myositis ossificans circumscripta is another synonym of myositis ossificans traumatica and refers to the new extraosseous bone that appears after trauma. It is caused by a premature return to activity after an injury.

Hereditary Myositis Ossificans

The second condition, myositis ossificans progressiva (also referred to as fibrodysplasia ossificans progressiva) is an inherited affliction with an autosomal dominant pattern. In this type, ossification can occur without injury and typically grows in a predictable pattern. Although this disorder can be passed to offspring by those afflicted with FOP, it is also classified as nonhereditary, as it is most often attributed to a spontaneous genetic mutation upon conception.

Treatment

For all types of myositis ossificans, nonsurgical treatments are usually recommended. This includes icing the bump, limiting activity to rest the area, gentle stretching, taking nonsteroidal anti-inflammatory drugs (NSAIDs), and using an elastic bandage to decrease swelling. Physical therapy can also be recommended to help increase strength, flexibility, and range of motion.

cyvigor

Heterotopic ossification causes

Heterotopic ossification (HO) occurs when bone tissue develops in soft tissues where bone growth does not usually occur. It is often the result of an injury or major surgery, but it may also occur for no known reason. It is a frequent complication in the rehabilitation setting, particularly in patients with burns, strokes, spinal cord injuries, traumatic amputations, joint replacements, and traumatic brain injuries.

HO can be classified into two main categories: traumatic and neurogenic. Traumatic HO arises from fractures, arthroplasty, muscular trauma, joint dislocations, and burns, while neurogenic HO is associated with strokes, spinal cord injuries, traumatic brain injuries, and brain tumours. The hips, elbows, shoulders, and knees are the most common sites for neurogenic HO. Uncommon sites include incisions, kidneys, the uterus, corpora cavernosum, and the gastrointestinal tract.

The exact cause of neurogenic HO remains unknown, but several risk factors have been identified, including spasticity, older age, pressure ulcers, deep vein thrombosis, tracheostomy, long bone fractures, prior injury, edema, immobility, and the severity of the injury. High-risk and moderate-risk factors in the THA population include men with bilateral THA, a prior history of HO, ankylosing spondylitis, diffuse idiopathic hyperostosis, and Paget's Disease.

Genetic HO is a rare form of the condition, affecting fewer than 5,000 people worldwide. It is caused by genetic diseases such as fibrodysplasia ossificans progressiva (FOP), Albright's hereditary osteodystrophy, and progressive osseous heteroplasia (POH). FOP can lead to misshapen fingers, toes, and spines, while POH results in bone growth in the subcutaneous fat between the skin and muscles, eventually spreading to deeper layers of soft and connective tissues.

The SCM Muscle: A Comprehensive Overview

You may want to see also

cyvigor

Diagnosis and treatment

Myositis ossificans is the most common form of heterotopic ossification, which occurs when bone tissue develops in soft tissues or muscles. It is usually the result of a traumatic injury, such as a direct impact to the quadriceps muscle, and is often mistaken for osteosarcoma. It can also develop without a known injury.

To diagnose myositis ossificans, a healthcare provider will perform a physical examination, including touching the bony lump to check for pain or warmth. They may also request imaging tests such as an X-ray, ultrasound, Positron Emission Tomography (PET) scan, or Magnetic Resonance Imaging (MRI). These imaging techniques can reveal the presence of calcification or faint soft tissue mineralization, which are indicative of myositis ossificans. However, in the early stages, imaging may not be conclusive, and a biopsy may be necessary to confirm the diagnosis.

There is no cure for myositis ossificans, and treatment focuses on managing symptoms and preventing further complications. Nonsurgical treatments, such as rest, icing the bump, compression, and gentle pain-free range-of-motion exercises, are often recommended as the first line of treatment. Analgesics, corticosteroids, and adrenocorticotropin may also be prescribed to manage pain and inflammation. In some cases, especially when non-surgical treatments fail or when there is severe pain or limitation of joint movement, surgery may be considered. However, surgery is generally delayed for 6 to 18 months after injury to avoid interfering with bone maturation and to reduce the risk of recurrence.

In the case of heterotopic ossification, the treatment depends on the symptoms, type of HO, and progression. Medications such as corticosteroids may be prescribed for flare-ups in people with genetic heterotopic ossification. Physical therapy can help increase the range of motion and reduce pain. Surgery is considered a last resort for removing heterotopic ossification that causes severe pain or restricts daily functioning. Preventive treatments, such as nonsteroidal anti-inflammatory drugs (NSAIDs) before or after surgery, can also be used to lower the risk of developing heterotopic ossification.

cyvigor

Fibrodysplasia ossificans progressiva

Heterotopic ossification (HO) is when bone tissue develops in soft tissues, often following an injury or surgery. This is different from Fibrodysplasia Ossificans Progressiva (FOP), a rare genetic mutation and type of HO, where bone tissue develops in skeletal muscles and soft connective tissues, progressively locking joints and restricting movement.

FOP is an extremely rare genetic connective tissue disorder characterised by the abnormal development of bone in areas of the body where bone is not normally present, such as ligaments, tendons and skeletal muscles. This disorder causes the body's skeletal muscles and soft connective tissues to undergo a transformation into bone, progressively locking joints in place and making movement difficult or impossible.

FOP was originally called myositis ossificans progressiva and was thought to be caused by muscular inflammation (myositis) that caused bone formation. The disease was renamed by Victor A. McKusick in 1970 following the discovery that soft tissue other than muscles (e.g. ligaments) were also affected by the disease process. The best-known case of FOP is that of Harry Eastlack (1933-1973). By the time of his death, his body had completely ossified, leaving him able to move only his lips.

FOP is an inherited affliction, an autosomal dominant pattern, in which ossification can occur without injury and typically grows in a predictable pattern. Variants in the ACVR1 gene cause FOP by disrupting mechanisms that control the receptor's activity. This results in too much receptor activity, leading to overgrowth and the signs and symptoms of FOP. Most cases of FOP result from new variants in the gene, occurring in people with no family history of the disorder. In rare cases, an affected person may inherit the variant from one parent.

Symptoms of FOP include malformed big toes present at birth, as well as short thumbs and other skeletal abnormalities. Any trauma to the muscles, such as a fall or invasive medical procedure, may trigger episodes of muscle swelling and inflammation followed by rapid ossification in the injured area. Flare-ups may also be caused by viral illnesses such as influenza. Over time, people with FOP may experience malnutrition and breathing difficulties due to restricted lung expansion.

cyvigor

Prevention

Myositis ossificans is a rare condition and the most common form of heterotopic ossification (HO). It occurs when bone tissue develops in soft tissues or muscles, often after a traumatic injury. The best way to manage this condition is to prevent its occurrence. Once myositis ossificans is established, there is little that can be done to accelerate bone resorption.

Preventing Myositis Ossificans

  • Treat injuries promptly — When injured, the body immediately starts making new cells to heal itself. Treating injuries right away can help prevent myositis ossificans. This includes following the RICE protocol: rest, ice, compression, and elevation.
  • Avoid premature return to activity — Most ossifications arise due to a premature return to activity after an injury. Allow the body to rest and heal adequately before resuming physical activities.
  • Physiotherapy — Gentle pain-free range-of-motion exercises can be introduced 48 to 72 hours after injury as long as they are performed within a pain-free range. Avoid aggressive limb physiotherapy in the initial stages to prevent worsening symptoms.
  • Strength training and stretching — Strength training and stretching can help prevent injuries and reduce the risk of myositis ossificans.

Preventing Heterotopic Ossification

  • Non-steroidal anti-inflammatory drugs (NSAIDs) — Taking NSAIDs before or immediately after surgery can decrease the risk of postsurgical HO.
  • Radiation therapy — Postoperative low-dose radiation therapy with an oral indomethacin regimen can help prevent heterotopic ossification after total hip replacement or hip arthroplasty.
  • Treat underlying conditions — Address any underlying conditions that increase the risk of HO, such as burns, stroke, spinal cord injury, traumatic amputation, joint replacement, or traumatic brain injury.
  • Surgical precautions — If you are at high risk for HO, discuss preventive treatments with your healthcare provider before undergoing orthopedic surgery.

Frequently asked questions

Ossification of muscle, or heterotopic ossification (HO), occurs when bone tissue develops in soft tissues or muscles. This usually occurs after an injury or major surgery, but can also be genetic.

The most common symptom of ossification of muscle is a painful, tender lump beneath the skin. This lump can restrict your range of motion, particularly if it is near a joint.

There is no cure for ossification of muscle. Doctors typically treat it with non-surgical methods, such as bed rest, ice therapy, compression, and elevation of the affected limb.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment